Financhill
Back

Perspective Therapeutics Stock Predictions

Perspective Therapeutics Stock Forecast

  • Is Perspective Therapeutics Stock Undervalued?
    The current Perspective Therapeutics [CATX] share price is $3.2200. The Score for CATX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Perspective Therapeutics Stock Go Up Next Year?

Data Unavailable

Perspective Therapeutics Stock Rating

Data Unavailable

Perspective Therapeutics Stock Price History

Is CATX stock going to rise?

  • The current trend is moderately bullish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NYAM
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
perspectivetherapeutics.com

52-Week Data

52-Week High:
16.5500
52-Week Low:
1.6000

Prediction Charts

Market Cap:
239M
Price in USD:
3.2200
Volume:
525K
Beta:
-72.5377

Technical Analysis

SMA50:
2.4388
SMA100:
2.6641
SMA200:
5.9171
52-Wk Change:
-75.79%

Stock Predictions

  • Is Perspective Therapeutics stock public?
    Yes, Perspective Therapeutics is a publicly traded company.
  • What is the Perspective Therapeutics stock quote today?
    The Perspective Therapeutics stock price is 3.2200 USD today.
  • How to buy Perspective Therapeutics stock online?
    You can buy Perspective Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-23 2.5100 2.3900 2.5550 2.3900
May-27 2.4800 2.4000 2.5450 2.3400
May-28 2.4000 2.5800 2.6850 2.4000
May-29 2.6000 2.7000 2.7550 2.6000
May-30 2.6700 2.5700 2.7700 2.5250
Jun-2 2.6800 2.3900 2.7100 2.3400
Jun-3 2.4400 3.0900 3.6600 2.4400
Jun-4 3.2100 3.1300 3.3800 3.0500
Jun-5 3.1000 3.1200 3.3500 2.9600
Jun-6 3.2100 3.3200 3.5700 3.1600
Jun-9 3.4300 3.2300 3.6000 3.2300
Jun-10 3.2500 3.4300 3.7000 3.2500
Jun-11 3.5200 3.2800 3.6600 3.2500
Jun-12 3.4000 3.2200 3.4100 3.1611

Perspective Therapeutics Earnings

Data Unavailable

Perspective Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.05 per share, a decrease this year of $0.35 per share, and a decrease next year of $0.17 per share.

* Perspective Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.